ANEBULO PHARMACEUTICALS INC (ANEB) Stock Balance Sheet
NASDAQ:ANEB - Nasdaq - US0345691036 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 13.28M | 3.09M | 11.25M | 14.55M | 19.99M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | 19.99M | |||
| Receivables | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 528.00K | 413.80K | 420.00K | 1.03M | 1.67M | |||
| Total Current Assets | 13.81M | 3.51M | 11.67M | 15.58M | 21.65M | |||
| Non-Current Assets | ||||||||
| Other Non-Current Assets | 200.60K | 565.10K | N/A | N/A | N/A | |||
| Total Non-Current Assets | 200.60K | 565.10K | 0.00 | 0.00 | 0.00 | |||
| TOTAL ASSETS | 14.01M | 4.07M | 11.67M | 15.58M | 21.65M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 118.50K | 104.20K | 530.00K | 130.00K | 130.00K | |||
| Accounts Payable | 427.60K | 156.40K | 530.00K | 380.00K | 110.00K | |||
| Total Current Liabilities | 546.00K | 260.60K | 1.07M | 510.00K | 240.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 546.00K | 260.60K | 1.07M | 510.00K | 240.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -71.74M | -65.40M | -57.20M | -45.47M | -38.64M | |||
| Additional Paid In Capital | 85.17M | 69.19M | 67.78M | 60.51M | 60.03M | |||
| Common Shares | 41.10K | 25.90K | 30.00K | 20.00K | 20.00K | |||
| Shares Outstanding | 41.08M | 25.93M | 25.63M | 23.34M | 23.34M | |||
| Tangible Book Value per Share | 0.33 | 0.15 | 0.41 | 0.65 | 0.92 | |||
| Total Shareholders' Equity | 13.46M | 3.81M | 10.60M | 15.07M | 21.41M | |||
| TOTAL LIABILITIES AND EQUITY | 14.01M | 4.07M | 11.67M | 15.58M | 21.65M | |||
| Statistics | ||||||||
| Current Ratio | 25.29 | 13.46 | 10.91 | 30.55 | 90.21 | |||
| Return On Assets (ROA) | -54.89% | -201.36% | -100.51% | -43.84% | -177.64% | |||
| Return On Equity (ROE) | -57.12% | -215.13% | -110.66% | -45.32% | -179.64% | |||
All data in USD , ROIC based on taxRate of 0.21